Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCD vs RCD in Waldenstrom's Macroglobulinemia
NCT02971982Phase 2Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Oct 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in Waldenstrom macroglobulinemia (WM), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
bortezomib
03
Conditions
Waldenstrom macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT02971982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02971982.